Trials / Recruiting
RecruitingNCT06409013
Evaluation of Tumor Resection Guided by Intraoperative Indocyanine Green Dye Fluorescence Angiography in Patients With Sarcoma
Sarcoma Resection Guided by Intraoperative Indocyanine Green Dye Fluorescence Angiography
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (estimated)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study evaluates the effectiveness of intraoperative indocyanine green dye and fluoroscopic technology in confirming negative margins after tumor removal.
Detailed description
PRIMARY OBJECTIVE: I. To evaluate the use of indocyanine green (ICG) as an intraoperative guide during bone and soft tissue sarcoma resection. OUTLINE: This is an observational study. Patients receive ICG infusion prior to undergoing scheduled resection and have medical records reviewed on study.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Non-Interventional Study | Non-interventional study |
Timeline
- Start date
- 2024-03-14
- Primary completion
- 2027-03-30
- Completion
- 2027-03-30
- First posted
- 2024-05-10
- Last updated
- 2026-02-06
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT06409013. Inclusion in this directory is not an endorsement.